What is the appropriate workup and management for a 41-year-old patient with mild normocytic anemia (red blood cell count 3.4 M/µL, hemoglobin 10.9 g/dL, hematocrit 31.6 %), elevated blood urea nitrogen 40 mg/dL, creatinine 1.15 mg/dL, elevated glucose, normal alanine aminotransferase (ALT) 30 U/L, aspartate aminotransferase (AST) 24 U/L, and thyroid‑stimulating hormone (TSH) 1.5 µIU/mL, who is taking fluoxetine (Prozac) 10 mg daily and quetiapine (Seroquel) 100 mg daily?

Workup and Management for Anemia with Kidney Dysfunction

This patient requires immediate evaluation for chronic kidney disease (CKD)-related anemia with iron studies (ferritin and transferrin saturation), reticulocyte count, and assessment for gastrointestinal blood loss, while addressing the elevated BUN/creatinine and glucose abnormalities that are likely driving the anemia.

Primary Concern: CKD-Related Anemia

The constellation of normocytic anemia (Hgb 10.9 g/dL, HCT 31.6%, RBC 3.4) with elevated BUN (40 mg/dL) and creatinine (1.15 mg/dL) strongly suggests anemia of chronic kidney disease. The anemia of CKD is characteristically normochromic and normocytic, making it indistinguishable from other chronic conditions without further workup 1.

Immediate Laboratory Workup Required:

Iron Studies (Priority #1):

• Serum ferritin - assesses tissue iron stores
• Transferrin saturation (TSAT) - evaluates iron available for erythropoiesis
• Mean corpuscular volume (MCV) - if not already calculated from CBC

The vitamin B12 already ordered is appropriate, but iron deficiency is the most common contributor to anemia in CKD 1. In non-dialysis CKD patients not on erythropoiesis-stimulating agents, finding iron deficiency should trigger careful assessment for gastrointestinal bleeding 1.

Additional Essential Tests:

• Reticulocyte count (absolute or reticulocyte index) - evaluates bone marrow response appropriateness 1
• Complete blood count with differential - assess all three cell lines (WBC, Hgb, platelets) as abnormalities in multiple lines warrant hematology consultation 1
• Fecal occult blood test - screen for GI blood loss 2
• Estimated GFR (eGFR) - calculate from creatinine to stage CKD

Medication Considerations

Seroquel (quetiapine) 100 mg daily: The drug label indicates quetiapine clearance is reduced by 30-50% in patients with renal impairment 3. While your patient's renal function shows only mild impairment, monitor closely for increased sedation or orthostasis. Recent evidence shows antipsychotics can cause hematological alterations including lower hemoglobin 4.

Prozac (fluoxetine) 10 mg daily: The dose is appropriately low. Recent data shows SSRIs can affect hepatic enzymes (ALT/AST) and electrolytes, though your patient's liver function is normal 5. SSRIs have been associated with hematological adverse effects, though rarely 6.

Critical Drug Interaction: Both medications can affect hemostasis. SSRIs interfere with platelet serotonin release, and when combined with NSAIDs or anticoagulants, increase bleeding risk 7. If GI bleeding is identified, avoid NSAIDs entirely.

Addressing the Elevated Glucose

The elevated glucose requires:

• Hemoglobin A1c - assess for diabetes or prediabetes
• Fasting glucose confirmation

This is crucial because diabetic patients with CKD have higher anemia prevalence regardless of kidney function level, develop anemia at earlier CKD stages, and require more frequent monitoring 1.

Management Algorithm

Step 1: Confirm CKD Stage

• Calculate eGFR from creatinine
• If eGFR <60 mL/min/1.73m², this confirms CKD Stage 3 or worse

Step 2: Iron Status Interpretation

• Absolute iron deficiency: TSAT <20% AND ferritin <100 μg/L → Investigate GI bleeding, then oral iron supplementation
• Functional iron deficiency: TSAT <20% AND ferritin >100 μg/L → Consider inflammation vs. kinetic deficiency 8
• If iron replete with persistent anemia → Likely erythropoietin deficiency from CKD

Step 3: Rule Out Other Causes

• Check B12 (already ordered) and folate if MCV trending low
• Review reticulocyte count: Low count with adequate iron/B12/folate suggests erythropoietin deficiency or bone marrow suppression 1
• If multiple cell lines affected → Hematology referral mandatory 1

Step 4: Address Underlying Conditions

• Control glucose (target HbA1c <7% to slow CKD progression)
• Optimize kidney function (consider nephrology referral if eGFR <45 or rapidly declining)
• Review medications for nephrotoxicity

Common Pitfalls to Avoid

1. Don't assume CKD is the sole cause - Iron deficiency is extremely common and treatable 1
2. Don't overlook GI bleeding - Especially given SSRI use affecting platelet function 7
3. Don't start erythropoiesis-stimulating agents prematurely - Iron stores must be adequate first 8
4. Don't ignore the glucose - Diabetes accelerates both CKD and anemia 1
5. Don't forget medication dose adjustments - Quetiapine clearance is reduced in renal impairment 3

Monitoring Plan

• Hemoglobin monitoring: At minimum yearly in CKD patients, but more frequently (every 3-6 months) given diabetes risk and current anemia 1
• Renal function: Every 3-6 months to track progression
• Iron studies: Recheck after iron supplementation if deficient
• Medication tolerability: Watch for increased quetiapine side effects with declining renal function

11873